What exactly is COVID Suraksha Mission?

  • The Government of India (GOI) has provided a Rs 900 crore stimulus package for Mission Covid Suraksha, the Indian Covid-19 Vaccine Development Mission.
  • The Department of Biotechnology (DBT) will receive this money for the research and development of the Indian Covid-19 vaccine.
  • Its goal is to promote Covid-19 vaccine development by establishing clinical trial locations and strengthening existing immunoassay labs, central laboratories, and adequate facilities for animal research, production facilities, and other test facilities.
  • So far, the DBT has backed a total of ten vaccine ideas in academia and business.
  • Five vaccine candidates are now in human testing, including the Russian vaccine Sputnik-V, with at least three more in advanced pre-clinical stages and expected to start human trials soon.
  • The formulation of a good target product profile would be a vital component, ensuring that vaccines supplied throughout the mission have favoured qualities that are applicable to India.
  • It will be executed by the Biotechnology Industry Research Assistance Council’s specialized Mission Implementation Unit (BIRAC)

Mission Covid Suraksha

The Indian government-sponsored “Mission COVID Suraksha,” a training program for Indian candidates and researchers working on the COVID-19 vaccine. The government will support the clinical research, production, and licensing of Indian vaccinations to combat the viral attack under this goal. The Mission was designed to be a National Mission to bring to the citizens of the country should be given a safe, effective, economical, and easily available COVID-19 vaccine as soon as possible, with an emphasis on AtmaNirbhar Bharat. The Mission’s purpose is to accelerate the creation of at least 5 to 6 COVID-19 vaccine candidates, with some of these being clinically tested and brought closer to licensing and market debut for regulatory consideration authority, as well as for implementation in public health systems. In this post, we will go over the funds set aside for this mission, as well as the goals and COVID vaccines being produced in India. This is especially significant in light of the approaching Government and Administrative examinations. 

Similar Reads

What exactly is COVID Suraksha Mission?

The Government of India (GOI) has provided a Rs 900 crore stimulus package for Mission Covid Suraksha, the Indian Covid-19 Vaccine Development Mission. The Department of Biotechnology (DBT) will receive this money for the research and development of the Indian Covid-19 vaccine. Its goal is to promote Covid-19 vaccine development by establishing clinical trial locations and strengthening existing immunoassay labs, central laboratories, and adequate facilities for animal research, production facilities, and other test facilities. So far, the DBT has backed a total of ten vaccine ideas in academia and business. Five vaccine candidates are now in human testing, including the Russian vaccine Sputnik-V, with at least three more in advanced pre-clinical stages and expected to start human trials soon. The formulation of a good target product profile would be a vital component, ensuring that vaccines supplied throughout the mission have favoured qualities that are applicable to India. It will be executed by the Biotechnology Industry Research Assistance Council’s specialized Mission Implementation Unit (BIRAC)...

COVID Suraksha Mission Objectives:

This mission’s primary objectives are as follows:...

COVID-19 Vaccine Types:

Inactivated vaccines :...

Vaccines Developed Throughout the World:

Each vaccine developed throughout the world to combat the spread of the Novel coronavirus must go through a clinical study. As previously stated, ten vaccinations were provided as part of the COVID Suraksha mission, but only a handful of them made it to the human trials stage....

Related Frequently Asked Questions & Answers:

1Q. List some of the candidates that are successfully worked on humans?...